Gilead’s Replacement HIV Drug Improves Kidney Effects in Study
Alert: HALISTER Source: BN (Bloomberg News)
Tickers GILD US (Gilead Sciences Inc)
People Brian Abrahams (Wachovia Securities Inc) John Milligan (Gilead Sciences Inc)
Topics AIDS Infectious Diseases
To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.
UUID: 7947283